paclitaxel has been researched along with Cancer of Paranasal Sinus in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Chera, BS; Grilley-Olson, JE; Lenze, NR; Murr, AT; Patel, SA; Shen, C; Sheth, SH; Thorp, BD; Weiss, JM; Zanation, AM | 1 |
Fujii, T; Fujiwara, K; Fukuhara, T; Koyama, S; Morisaki, T; Nakamura, Y; Takeuchi, H | 1 |
Dietz, A; Mekonnen, B; Mozet, C; Stumpp, P | 1 |
Blumenschein, G; Clayman, G; Diaz, EM; Garden, AS; Gillenwater, A; Ginsberg, LE; Glisson, BS; Goepfert, H; Hong, WK; Kies, MS; Lippman, SM; Liu, DD; Morrison, WH; Papadimitrakopoulou, VA; Schommer, D | 1 |
DeMonte, F; El-Naggar, AK; Hanna, EY; Mishra, A | 1 |
1 review(s) available for paclitaxel and Cancer of Paranasal Sinus
Article | Year |
---|---|
[Therapeutic options in sinunasal adenoid cystic carcinomas--a case report and review].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenoid Cystic; Chemotherapy, Adjuvant; Combined Modality Therapy; Endoscopy; Female; Humans; Magnetic Resonance Imaging; Neoplasm Invasiveness; Neoplasm Staging; Neoplasm, Residual; Orbit; Paclitaxel; Paranasal Sinus Neoplasms; Pterygopalatine Fossa; Radiotherapy, Adjuvant; Skull Neoplasms; Sphenoid Bone; Sphenoid Sinus; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2009 |
1 trial(s) available for paclitaxel and Cancer of Paranasal Sinus
Article | Year |
---|---|
Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Eye Enucleation; Female; Humans; Ifosfamide; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Orbit; Paclitaxel; Paranasal Sinus Neoplasms; Radiotherapy, Adjuvant; Treatment Outcome | 2003 |
3 other study(ies) available for paclitaxel and Cancer of Paranasal Sinus
Article | Year |
---|---|
Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Humans; Induction Chemotherapy; Neoplasm Staging; Paclitaxel; Paranasal Sinus Neoplasms; Squamous Cell Carcinoma of Head and Neck; Standard of Care | 2022 |
Cetuximab and paclitaxel combination therapy for recurrent basaloid squamous cell carcinoma in the ethmoid sinus.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Ethmoid Sinus; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Paclitaxel; Paranasal Sinus Neoplasms; Positron-Emission Tomography | 2021 |
Endodermal sinus tumor of the paranasal sinuses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Endodermal Sinus Tumor; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Middle Aged; Nasal Obstruction; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Paclitaxel; Paranasal Sinus Neoplasms; Radiotherapy, Adjuvant; Skull Base | 2008 |